2-Bromo-N-[6-(1H-pyrazol-1-yl)pyridin-3-yl]acetamide hydrobromide

Catalog No.: 
ACAKVQ708
CAS No.: 
1384428-31-2
Molecular Formula: 
C10H10Br2N4O
Molecular Weight: 
362.02
2-Bromo-N-[6-(1H-pyrazol-1-yl)pyridin-3-yl]acetamide hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$236.00InquiryInquiry
100mg95%$339.00InquiryInquiry
250mg95%$476.00InquiryInquiry
1g95%$946.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-N-[6-(1H-pyrazol-1-yl)pyridin-3-yl]acetamide hydrobromide
IUPAC NameN-(6-(1H-pyrazol-1-yl)pyridin-3-yl)-2-bromoacetamide hydrobromide
MDL No.MFCD22196542
Molecular FormulaC10H10Br2N4O
Molecular Weight362.02
SMILESO=C(NC1=CC=C(N2N=CC=C2)N=C1)CBr.[H]Br
InChI KeyLUZVIYYYBGXOCG-UHFFFAOYSA-N
Synonym2-bromo-N-[6-(1H-pyrazol-1-yl)pyridin-3-yl]acetamide hydrobromide
CAS No.1384428-31-2

Synthetic Route by SureRoute

1. ACAKVQ708 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEAPI438 route compound structure diagram
    ACEAPI438154095-29-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAKVQ708 route product structure diagram
    ACAKVQ7081384428-31-2
Inquiry

2. ACAKVQ708 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEAPI438 route compound structure diagram
    ACEAPI438154095-29-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAKVQ708 route product structure diagram
    ACAKVQ7081384428-31-2
Inquiry

3. ACAKVQ708 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEAPI438 route compound structure diagram
    ACEAPI438154095-29-1In Stock
  2. Plus
  3. ACPTFB326 route compound structure diagram
    ACPTFB3261068-52-6In Stock
  4. Then
  5. ACAKVQ708 route product structure diagram
    ACAKVQ7081384428-31-2
Inquiry

Comments (0)